Tag: non-steroidal anti-inflammatory drugs market research report

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How Much Growth is Expected for the Non-Steroidal Anti-inflammatory Drugs Market from 2024 to 2033?

The market size for non-steroidal anti-inflammatory drugs has seen significant growth in previous years. The market, which is projected to expand from $19.56 billion in 2023 to $20.93 billion in 2024, will achieve a compound annual growth rate (CAGR) of 7.0%. The increase in this historical period can be credited to factors such as chronic inflammatory diseases, management of pain after surgery, sports-related injuries, over-the-counter accessibility, an aging demographic, and consumer awareness.

Expectations are high for significant expansion of the non-steroidal anti-inflammatory drugs market in the upcoming years. The market size is anticipated to reach $27.09 billion by 2028, growing at a compound annual growth rate (CAGR) of 6.7%. This expected expansion during the forecast period can be connected to the advent of new pain management therapies, regulatory modifications, the usage of telehealth, worldwide wellness trends, competition from biosimilars, patient preferences, and precision medicine methodologies. Key trends for the forecast period involve a dominant over-the-counter (otc) market, an increased inclination towards cox-2 inhibitors, competition between generics and the market, and the incorporation of digital health technologies.

Claim Your Free Sample of the Global Non-Steroidal Anti-inflammatory Drugs Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

What Factors Are Encouraging Growth in the non-steroidal anti-inflammatory drugs Market?

The escalating prevalence of chronic pain is anticipated to drive the expansion of the non-steroidal anti-inflammatory drugs market in the coming times. Chronic pain signifies a discomfort that lasts over half a year. Non-steroidal anti-inflammatory drugs are employed to mend injuries and deal with chronic pain. For instance, the CDC (Centers for Disease Control and Prevention), a government agency based in the US, reported in April 2022 that arthritis was often the cause of chronic pain, affecting a large population in the US. Roughly one in four adults among 15 million sufferers endure severe joint pain related to arthritis. Hence, the escalating rate of chronic pain propels the expansion of the non-steroidal anti-inflammatory drugs market.

Which Key Segments Shape the Non-Steroidal Anti-inflammatory Drugs Market?

The non-steroidal anti-inflammatory drugs market covered in this report is segmented –

1) By Route of Administration: Oral, Topical, Other Route of Administration

2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What Trends Are Driving Change in the Non-Steroidal Anti-inflammatory Drugs Market?

A dominant trend within the non-steroidal anti-inflammatory drugs market is the development of innovative products. Significant players in this industry are focusing on the invention of new technological solutions. For instance, Ono and Seikagaku, a company in Japan that specializes in non-steroidal anti-inflammatory drugs, unveiled JOYCLU, a 30 mg intra-articular injection in May 2021. This preparation uses Seikagaku’s unique technology to chemically conjoin hyaluronic acid with diclofenac, an anti-inflammatory drug. Purposed to discharge diclofenac in the joint through hydrolysis, it is approved for treating osteoarthritis and is anticipated to alleviate symptoms following a four-week intra-articular injection. Administered as an injection directly into the joint cavity, it minimizes systemic exposure to diclofenac, thereby reducing the likelihood of a systemic adverse drug reaction. This is the first drug of its kind in Japan to be indicated for hip joint osteoarthritis among joint function enhancement drugs.

Order Now for Fast Delivery of Your Non-Steroidal Anti-inflammatory Drugs Market Report!

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

What Regions Are Contributing Significantly to the Growth of the Non-Steroidal Anti-inflammatory Drugs Market?

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the non-steroidal anti-inflammatory drugs market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Non-Steroidal Anti-inflammatory Drugs Market Include

1. Non-Steroidal Anti-inflammatory Drugs Market Executive Summary

2. Non-Steroidal Anti-inflammatory Drugs Market Segments

3. Non-Steroidal Anti-inflammatory Drugs Market Size And Template Market Growth Rate

4. Key Non-Steroidal Anti-inflammatory Drugs Market Trends

5. Major Non-Steroidal Anti-inflammatory Drugs Market Drivers

……

25. Key Mergers And Acquisitions In The Non-Steroidal Anti-inflammatory Drugs Market

26. Top Non-Steroidal Anti-inflammatory Drugs Companies

27. Non-Steroidal Anti-inflammatory Drugs Market Opportunities And Strategies

28. Non-Steroidal Anti-inflammatory Drugs Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Nucleic Acid Based Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024, the non-steroidal anti-inflammatory drugs market is expected to show significant growth in the forecast period.

The non-steroidal anti-inflammatory drugs (NSAIDs) market has experienced robust growth in recent years, fueled by various factors shaping the landscape of pain management and healthcare. Here’s a comprehensive look at the market trends and projections:

Market Growth and Projections

• The NSAIDs market is set to grow from $19.56 billion in 2023 to $20.93 billion in 2024, showcasing a compound annual growth rate (CAGR) of 7.0%.
• By 2028, the market is expected to reach $27.09 billion, maintaining a steady CAGR of 6.7%.
• Growth drivers include the rising prevalence of chronic pain, advancements in pain management therapies, and regulatory changes facilitating market expansion.

Driving Forces Behind Market Growth

1. Rising Prevalence of Chronic Pain

• Chronic pain, persisting for more than six months, is becoming increasingly prevalent, with conditions like arthritis affecting millions globally.
• NSAIDs play a crucial role in managing chronic pain, offering relief and improving the quality of life for patients.

2. Emphasis on Product Innovations

• Product innovation remains a focal point for companies in the NSAIDs market, driving advancements in technology and formulations.
• Innovations like intra-articular injections, such as JOYCLU, exemplify efforts to enhance drug delivery and efficacy.

View More On The Non-Steroidal Anti-inflammatory Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

3. Strategic Acquisitions and Portfolio Expansions

• Strategic acquisitions, like Pfizer’s acquisition of Arena Pharmaceuticals, enable companies to diversify their portfolios and expand therapeutic offerings.
• Pfizer’s acquisition brings forth promising pipeline candidates, addressing immuno-inflammatory diseases and expanding treatment options.

Market Segmentation

• The NSAIDs market is segmented by route of administration, disease indication, and distribution channel, catering to diverse patient needs and healthcare settings.
• Routes of administration include oral, topical, and other specialized routes, ensuring versatility in treatment options.
• Disease indications span arthritis, migraine, ophthalmic diseases, and other conditions, addressing a wide spectrum of health concerns.
• Distribution channels encompass hospital pharmacies, retail pharmacies, and online platforms, enhancing accessibility to NSAID therapies.

Regional Dynamics

• North America emerged as the largest region in the NSAIDs market in 2023, driven by robust healthcare infrastructure and high disease burden.
• The Asia-Pacific region is anticipated to witness significant growth, fueled by increasing healthcare investments and rising awareness about pain management.

Future Trends and Outlook

• Over-the-counter (OTC) dominance and the rising preference for cox-2 inhibitors are expected to shape market dynamics in the forecast period.
• Generics and market competition will intensify, fostering innovation and affordability in NSAID therapies.
• Integration of digital health technologies, including telemedicine and remote monitoring, will revolutionize patient care and treatment outcomes.

In Conclusion
As the NSAIDs market continues to evolve, driven by advancements in pain management and healthcare delivery, opportunities emerge for stakeholders to innovate and collaborate. With a growing emphasis on patient-centric care and precision medicine approaches, the journey towards addressing chronic pain and improving patient outcomes remains at the forefront of pharmaceutical innovation. As we navigate the dynamic landscape of the NSAIDs market, embracing technological advancements and therapeutic breakthroughs, the quest for enhanced quality of life and pain relief for patients remains paramount.

Request A Sample Of The Global Non-Steroidal Anti-inflammatory Drugs Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8023&type=smp